Clinical Trial Update: Celebrex and Metformin for Postoperative Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating Celebrex (celecoxib) and Metformin for postoperative hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• CELEBREX (Celecoxib)
• metformin (metformin)

Snippet

Sponsor: Guangxi Medical University | Conditions: Liver Cancer | Phase 3 | Status: UNKNOWN